CFI-402257

CFI-402257
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T22289-1mg 1 mg

7 - 10 business days*

65.00€
TGM-T22289-5mg 5 mg

7 - 10 business days*

153.00€
TGM-T22289-10mg 10 mg

7 - 10 business days*

219.00€
TGM-T22289-25mg 25 mg

7 - 10 business days*

401.00€
TGM-T22289-50mg 50 mg

7 - 10 business days*

600.00€
 
Description: CFI-402257 is a selective inhibitor of Mps1/TTK kinase (Mps1 Ki = 0.09 nM, EC50 =... more
Product information "CFI-402257"
Description: CFI-402257 is a selective inhibitor of Mps1/TTK kinase (Mps1 Ki = 0.09 nM, EC50 = 6.5 nM)and can be used in studies about hepatocellular carcinoma diseases. Target: Kinesin. Smiles: N(C[C@H]1C[C@@](C)(O)C1)C=2N3C(=C(C=N3)C4=CC(C)=C(C(NC5CC5)=O)C=C4)N=C(OC=6C=CC=NC6)C2. References: Chan CY, et al. CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma. Proc Natl Acad Sci U S A. 2022 Aug 9,119(32):e2119514119.
Supplier: TargetMol
Supplier-Nr: T22289

Properties

Application: MPS1/TTK inhibitor
MW: 498.58 D
Formula: C28H30N6O3

Database Information

CAS : 1610759-22-2| Matching products
KEGG ID : K08866 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +20°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "CFI-402257"
Write a review
or to review a product.
Viewed